Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier

Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier

Abstract Recently, immune checkpoint inhibitors (ICIs) therapy has become a promising therapeutic strategy with encouraging therapeutic outcomes due to their durable anti-tumor effects. Though, tumor inherent or acquired resistance to ICIs accompanied with treatment-related toxicities hamper their c...

Full description

Bibliographic Details
Main Authors: Somayeh Vafaei, Angelina O. Zekiy, Ramadhan Ado Khanamir, Burhan Abdullah Zaman, Arman Ghayourvahdat, Hannaneh Azimizonuzi, Majid Zamani
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Cancer Cell International
Subjects:
Immune-checkpoint inhibitors (ICIs)
Tumor microenvironment (TME)
Resistance
Combination therapy
Immune cells
Online Access:https://doi.org/10.1186/s12935-021-02407-8

Internet

https://doi.org/10.1186/s12935-021-02407-8

Similar Items